
HireRight Holdings Corporation
HireRight Holdings Corporation (HRT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HRT · as of Jun 9, 2026
Key Statistics
Explore HireRight Holdings Corporation Data
hrt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 44.4%
The HRT analyst consensus is Hold, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $14.00, representing -2.51% downside from the current price of $14.36.
Competitors & Peers
hrt competitorsStock Performance
Full HistoryAbout HireRight Holdings Corporation
HireRight Holdings Corporation offers technology-driven solutions for global workforce risk management and compliance. The company provides a comprehensive suite of services to its clientele, encompas…
what is hireright holdings corporation · hrt stock overview · hireright holdings corporation company profile · who is hireright holdings corporation ceo · hrt NYSE · hireright holdings corporation headquarters · hireright holdings corporation business segments
About Stock Overview & Key Data
HireRight Holdings Corporation (HRT) is a Industrials company in the Staffing & Employment Services industry, listed on NYSE since Oct 29, 2021. As of the latest trading session, HRT stock price is $14.36, with a market capitalization of $967.2M. The stock has returned +36.89% over the past 12 months and +10.63% year-to-date.
According to 9 Wall Street analysts, the consensus rating for HireRight Holdings Corporation stock is Hold, with an average 12-month price target of $14.00. In fiscal year 2023, HireRight Holdings Corporation reported revenue of $721.9M and net income of -$11.6M. For detailed data — including HireRight Holdings Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, HireRight Holdings Corporation (HRT) stock price is $14.36. The stock is traded on NYSE under the ticker symbol HRT. The 52-week range is $8.69 – $14.39.